Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Increased Sales Driving Generic Drug Makers Higher
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 05/15/12 -- has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Drugs - Generic industry and are offering free analytical research on (NASDAQ: MYL) and (NYSE: WPI). Register with us today at to have free access to these research reports.
Generic drug makers such as Mylan Inc. and Watson Pharmaceuticals Inc. have been benefitting from increased sales as of late. Major drugs from the much talked about patent cliff group are now being produced by generic players, and the effect on quarterly earnings has been rosy. While sales and profits have been up, a number of lawsuits involving several companies are ongoing, as branded drug makers and rival generic companies vie for production rights. Get your free reports on and at . There is no commitment to join.
is the Ultimate Trading Environment for investors. If you are considering owning Mylan Inc. and Watson Pharmaceuticals Inc. then you should sign up for a free membership and our complimentary reports today at . Over the last 5 years our returns outpaced any of the major indexes. Sign up today to find out what you are missing.
Watson Pharmaceuticals, which began producing a generic version of Lipitor in November of last year, saw its 1st quarter earnings per share increase by $0.75 year-over-year to $1.64. Its Global Generics division saw sales jump by 86%, and total revenues for the quarter were $1.52 billion, considerably higher than sales from the same period last year. report is accessible for free by registering today at .
Mylan also turned in a strong 1st quarter, with earnings rising by over 18% year-over-year. report is accessible for free by registering today at .
The two stocks research reports are available for free by signing up now on .
Shine's Rooms is the brainchild of David Shine, a 13-year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting-edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.
To view our visit this link .
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.05.2012 - 12:05 Uhr
Sprache: Deutsch
News-ID 146527
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 994 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Increased Sales Driving Generic Drug Makers Higher"
steht unter der journalistisch-redaktionellen Verantwortung von
Shinesrooms.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
